Carregant...
Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials
BACKGROUND/AIMS: To evaluate the efficacy of antivascular endothelial growth factor (anti-VEGF) agents pretreatment before vitrectomy for patients with complicated proliferative diabetic retinopathy (PDR). METHODS: The PubMed, Embase and the Cochrane Central Register of Controlled Trials were search...
Guardat en:
| Publicat a: | Br J Ophthalmol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6059039/ https://ncbi.nlm.nih.gov/pubmed/29246890 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-311344 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|